Advances in separation methods for the use of platelet-rich fibrin in tissue repair: an integrative review
- PMID: 36825976
Advances in separation methods for the use of platelet-rich fibrin in tissue repair: an integrative review
Abstract
Plasma preparations originating from the centrifugation of blood samples, such as platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), have proven useful for the treatment of gingival recession due to their rich concentration of cells and cytokines fundamental in the mechanisms of both soft tissue and hard tissue repair. Depending on the preparation method used to generate PRP and PRF, different concentrations of plasma elements and physicochemical characteristics can be obtained. This study sought to perform an integrative literature review to compile the available data on different protocols for generating plasma preparations and their indications, benefits, and results. A descriptive research method was adopted for assessing the literature on processes for obtaining PRF, and articles indexed in the MEDLINE database were searched. The literature review showed that changes in the PRF protocols for obtaining blood concentrates have led to better isolation of cells and growth factors and more promising results in tissue repair. The evolution in protocols has resulted in various forms of PRF with different components: (1) a membrane that aggregates platelets and leukocytes (L-PRF); (2) a PRF rich in growth factors and cytokines, known as advanced PRF (A-PRF); (3) a liquid phase called injectable PRF (I-PRF) that shows greater cell accumulation than L-PRF; (4) A-PRF plus (A-PDF+), which improved the release of growth factors for a period of 10 days; and (5) concentrated PRF (C-PRF) obtained by progressive pipetting, which has the greatest cell accumulation among all of the types of platelet aggregates. Subsequently, the observation that the speed of centrifugation influenced the acquisition of specific cells resulted in the development of the low-speed centrifugation concept. Then, it was determined that reduction of the relative centrifugation forces significantly increased the number of platelets, leukocytes, and growth factors. Recently, evaluation of the centrifugation angle revealed greater entrapment of large cells, such as red blood cells, when centrifugation was changed from a fixed to a horizontal angle. Tissue bioengineering studies are allowing for significant advances in the process of obtaining blood components and enabling their use for tissue repair with greater predictability and less morbidity.
Keywords: gingival recession; integrative review; platelet-rich fibrin; tissue repair.
Conflict of interest statement
No conflicts of interest reported.
Similar articles
-
The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane.Platelets. 2018 Mar;29(2):171-184. doi: 10.1080/09537104.2017.1293812. Epub 2017 Apr 24. Platelets. 2018. PMID: 28437133
-
Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients' own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept.Eur J Trauma Emerg Surg. 2018 Feb;44(1):87-95. doi: 10.1007/s00068-017-0767-9. Epub 2017 Mar 10. Eur J Trauma Emerg Surg. 2018. PMID: 28283682 Free PMC article.
-
Improved growth factor delivery and cellular activity using concentrated platelet-rich fibrin (C-PRF) when compared with traditional injectable (i-PRF) protocols.Clin Oral Investig. 2020 Dec;24(12):4373-4383. doi: 10.1007/s00784-020-03303-7. Epub 2020 May 7. Clin Oral Investig. 2020. PMID: 32382929
-
Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF).Curr Pharm Biotechnol. 2012 Jun;13(7):1145-52. doi: 10.2174/138920112800624382. Curr Pharm Biotechnol. 2012. PMID: 21740377 Review.
-
Autologous platelet concentrates in maxillofacial regenerative therapy.Kaohsiung J Med Sci. 2020 May;36(5):305-310. doi: 10.1002/kjm2.12192. Epub 2020 Feb 12. Kaohsiung J Med Sci. 2020. PMID: 32052598 Review.
Cited by
-
Delayed centrifugation weakens the in vitro biological properties of platelet-rich fibrin membranes.Clin Oral Investig. 2024 Mar 22;28(4):225. doi: 10.1007/s00784-024-05617-2. Clin Oral Investig. 2024. PMID: 38514526
-
Research Hotspots and Trends of Bone Xenograft in Clinical Procedures: A Bibliometric and Visual Analysis of the Past Decade.Bioengineering (Basel). 2023 Aug 4;10(8):929. doi: 10.3390/bioengineering10080929. Bioengineering (Basel). 2023. PMID: 37627814 Free PMC article.
-
Leukocytes within Autologous Blood Concentrates Have No Impact on the Growth and Proliferation of Human Primary Osteoblasts: An In Vitro Study.Int J Mol Sci. 2024 Apr 21;25(8):4542. doi: 10.3390/ijms25084542. Int J Mol Sci. 2024. PMID: 38674127 Free PMC article.
-
The Association of Nanostructured Carbonated Hydroxyapatite with Denatured Albumin and Platelet-Rich Fibrin: Impacts on Growth Factors Release and Osteoblast Behavior.J Funct Biomater. 2024 Jan 5;15(1):18. doi: 10.3390/jfb15010018. J Funct Biomater. 2024. PMID: 38248685 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous